Description

Thymosin Alpha-1 (Tα1) – 10mg

Thymosin Alpha-1 is a 28-amino acid synthetic peptide originally isolated from thymic tissue. It is studied extensively in laboratory settings for its role in immune system modulation, T-cell differentiation, and cytokine signaling pathways.

This peptide is engineered strictly for laboratory investigation into adaptive immune response regulation, antiviral pathway research, and inflammatory signaling modulation.

Purity: >99% (HPLC Tested)
Format: Lyophilized White Powder
Molecular Formula: C129H215N33O55
Research Target: T-Cell Activation & Immune Modulation Pathways

Thymosin Alpha-1 is known for its regulatory effects on both innate and adaptive immune signaling. In controlled laboratory models, it has demonstrated influence on T-lymphocyte maturation, dendritic cell activation, and modulation of cytokines such as IL-2, IL-6, and interferon-gamma. Its broad immune signaling profile makes it central to immunological research applications.

Research Observed Outcomes

Data from immunological and translational research programs highlight the following findings in controlled laboratory models:

T-Cell Differentiation Research:
Studies indicate enhanced maturation and activation markers in T-lymphocyte populations.

Cytokine Regulation:
Laboratory investigations demonstrate modulation of pro- and anti-inflammatory cytokine balance.

Antiviral Pathway Activation:
Research suggests stimulation of interferon-mediated immune defense pathways in viral response models.

Immune System Balance:
Thymosin Alpha-1 has been studied for restoring immune homeostasis under immunosuppressive stress conditions.

Inflammatory Signal Modulation:
Experimental models show regulated NF-kB pathway activity and improved immune signaling balance.

Key Linked Studies & Research References

Thymosin Alpha-1 Immunology:
Goldstein, A.L., et al. (1977). “Isolation and characterization of thymosin alpha-1.” Proceedings of the National Academy of Sciences.

Immune Modulation Research:
Romani, L., et al. (2007). “Thymosin alpha-1: immune regulator.” Annals of the New York Academy of Sciences.

Antiviral Signaling Studies:
Garaci, E., et al. (2012). “Thymosin alpha-1 in viral infections.” International Immunopharmacology.

Cytokine & T-Cell Research:
King, R., & Tuthill, C. (2004). “Mechanisms of thymosin alpha-1.” Expert Opinion on Biological Therapy.

Storage & Stability Protocols

To preserve peptide structure and biological signaling integrity:

Lyophilized Powder:
Store at -20°C for long-term stability. Stable at room temperature for short-term transit.

Reconstituted Stability (Bacteriostatic Water):
When reconstituted under sterile laboratory conditions, solution stability is typically maintained for 4–6 weeks under refrigeration (2°C – 8°C).

Reconstituted Stability (Sterile Water):
Stability is significantly shorter, typically 7–12 days due to absence of antimicrobial preservatives.

Handling:
Avoid repeated freeze-thaw cycles. Protect from excessive heat, light, and agitation during reconstitution.

⚠️ STRICT COMPLIANCE NOTICE: FOR LABORATORY RESEARCH ONLY
This product is a chemical research peptide intended strictly for in vitro or laboratory experimentation. Any form of ingestion, injection, or topical application to humans or animals is STRICTLY PROHIBITED. This product is not a drug, food, or cosmetic and has not been approved by the FDA for any medical application. Handling must be performed by qualified professionals in controlled laboratory environments.